Victrex plc (VCT) Insider Martin Court Buys 7 Shares
Victrex plc (LON:VCT) insider Martin Court bought 7 shares of the business’s stock in a transaction on Friday, June 16th. The shares were acquired at an average cost of GBX 1,848 ($23.54) per share, with a total value of £129.36 ($164.81).
Martin Court also recently made the following trade(s):
- On Tuesday, May 16th, Martin Court bought 6 shares of Victrex plc stock. The shares were acquired at an average cost of GBX 2,011 ($25.62) per share, with a total value of £120.66 ($153.73).
- On Tuesday, April 18th, Martin Court bought 7 shares of Victrex plc stock. The shares were acquired at an average cost of GBX 1,928 ($24.56) per share, with a total value of £134.96 ($171.95).
Shares of Victrex plc (VCT) traded up 1.22% during mid-day trading on Monday, reaching GBX 1903.00. The company’s stock had a trading volume of 182,713 shares. The firm’s market capitalization is GBX 1.63 billion. Victrex plc has a 52 week low of GBX 1,364.00 and a 52 week high of GBX 2,063.00. The firm has a 50-day moving average of GBX 1,945.58 and a 200-day moving average of GBX 1,917.43.
The firm also recently announced a dividend, which will be paid on Friday, June 30th. Stockholders of record on Thursday, June 8th will be paid a dividend of GBX 12.20 ($0.16) per share. The ex-dividend date is Thursday, June 8th. This represents a dividend yield of 0.61%.
WARNING: “Victrex plc (VCT) Insider Martin Court Buys 7 Shares” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/06/19/victrex-plc-vct-insider-martin-court-buys-7-shares.html.
VCT has been the subject of several recent analyst reports. Barclays PLC reissued an “equal weight” rating and set a GBX 1,940 ($24.72) target price (up previously from GBX 1,600 ($20.38)) on shares of Victrex plc in a research note on Friday, April 28th. Liberum Capital reaffirmed a “buy” rating and issued a GBX 2,240 ($28.54) price objective on shares of Victrex plc in a research note on Tuesday, March 14th. Deutsche Bank AG reaffirmed a “hold” rating and issued a GBX 1,775 ($22.61) price objective on shares of Victrex plc in a research note on Wednesday, March 29th. J P Morgan Chase & Co reaffirmed a “neutral” rating and issued a GBX 1,550 ($19.75) price objective on shares of Victrex plc in a research note on Wednesday, March 29th. Finally, Numis Securities Ltd lifted their price objective on Victrex plc from GBX 2,042 ($26.02) to GBX 2,060 ($26.25) and gave the company a “hold” rating in a research note on Friday, April 7th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of GBX 1,974 ($25.15).
About Victrex plc
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with MarketBeat.com's FREE daily email newsletter.